Amending the Food and Drug Regulations to provide expedited access to COVID-19 drugs: Closed consultation 

From: Health Canada

Current status: Closed

This consultation ran from November 30th, 2020 to December 21st, 2020. See the What was heard: Consultation on interim order transition for COVID-19 drugs report for summaries of the discussions that took place.

The Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 introduced new regulatory pathways to expedite the authorization of COVID-19 drugs to meet a public health emergency without compromising patient safety. The interim order (IO) expires on September 16, 2021. To ensure uninterrupted access to these drugs, Health Canada proposed to amend the Food and Drug Regulations.

Who was the focus of this consultation

We engaged with:

Key questions for discussion

Industry plays an important role in facilitating early access to these drugs. Through this consultation, Health Canada wanted to make sure key stakeholders:

Ideas and input were sought on:

The input gathered through this process will help Health Canada’s work on amending the Food and Drug Regulations to ensure that Canadians continue to have access to COVID-19 drugs.

What we heard

Final report

Contact us

Contact us by email: hc.hpfb-covid19-dgpsa.sc@canada.ca

Related links

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: